EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomics-based identification of shared biomarkers across type 2 diabetes, mild cognitive impairment, and uric acid metabolism

Yan Liu, Dongmei Kang, Yuan Lei

Experimental Biology and Medicine · 06.07.2026 · 251

DOI: 10.3389/ebm.2026.11060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, online erschienen am 06.07.2026. Verfasst von Yan Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Biomarkers, Uric Acid, Cognitive Dysfunction. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uric acid metabolism is associated with the development of type 2 diabetes mellitus (T2DM), cardiometabolic, and cardiovascular diseases. Additionally, T2DM patients often exhibit mild cognitive impairment (MCI). However, the underlying mechanisms remain unclear. This study aims to identify and validate biomarkers associated with uric acid metabolism in T2DM and MCI, with the goal of discovering potential diagnostic and therapeutic targets to improve the quality of life for T2DM patients. Transcriptomic data for T2DM, MCI and uric acid metabolism-related genes were sourced from public databases. Biomarkers were screened using machine learning and validated for expression. Subsequent analyses included functional enrichment, immune infiltration, subcellular localization, and drug prediction. Three biomarkers—HP, ITGB3, and SELP—were identified. All showed significantly elevated expression in the T2DM group (p < 0.05). HP and ITGB3 were primarily enriched in ribosome-related pathways, primary immunodeficiency, and adherens junction processes. Immune infiltration analysis revealed that immature B cells and plasmacytoid dendritic cells were significantly enriched in T2DM. HP showed the strongest positive correlation with plasmacytoid dendritic cells (cor = 0.65, FDR <0.05), while ITGB3 exhibited the strongest positive correlation with immature B cells (cor = 0.76, FDR <0.05). Several potential therapeutic drugs were predicted, including calcifediol (score = −99.93) and meclofenamic acid (score = −99.89). This study identified three candidate biomarkers co-dysregulated across T2DM and MCI transcriptomes and associated with uric acid metabolism. Given the exploratory sample sizes, these findings are considered hypothesis-generating and require validation in larger independent cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2BiomarkersUric AcidCognitive DysfunctionTranscriptomeHumansGene Expression Profiling

Stichwörter der Autor:innen

biomarkersimmune infiltrationmild cognitive impairmenttype 2 diabetes mellitusuric acid metabolism

Substanzen

BiomarkersUric Acid

Autor:innen und Institutionen

  • Endocrinology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Anhui Public Health Clinical Center, Hefei, Anhui, China.
  • International Medical Department, The First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei, Anhui, China.

Zitieren

APA

Liu, Y., Kang, D., & Lei, Y. (2026). Transcriptomics-based identification of shared biomarkers across type 2 diabetes, mild cognitive impairment, and uric acid metabolism. Experimental Biology and Medicine, 251. https://doi.org/10.3389/ebm.2026.11060

Vancouver

Liu Y, Kang D, Lei Y. Transcriptomics-based identification of shared biomarkers across type 2 diabetes, mild cognitive impairment, and uric acid metabolism. Experimental Biology and Medicine. 2026;251. doi:10.3389/ebm.2026.11060

BibTeX
@article{Liu2026,
  author = {Liu, Yan and Kang, Dongmei and Lei, Yuan},
  title = {Transcriptomics-based identification of shared biomarkers across type 2 diabetes, mild cognitive impairment, and uric acid metabolism},
  journal = {Experimental Biology and Medicine},
  year = {2026},
  volume = {251},
  doi = {10.3389/ebm.2026.11060}
}
Kostenlos starten →